Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, selectively induces growth suppression and cell death of endometrial stromal sarcoma cells in vitro

被引：0
|
作者：
Hrzenjak, Andelko [1 ]
Moinfar, Farid [1 ]
Kremser, Marie-Luise [1 ]
Strohmeier, Bettina [1 ]
Zatloukal, Kurt [1 ]
Denk, Helmut [1 ]
机构：
[1] Med Univ Graz, Dept Pathol, Graz, Austria
来源：
VIRCHOWS ARCHIV | 2007年 / 451卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：401 / 401
页数：1
相关论文
共 50 条
  • [41] Synergistic effects of combined treatment with histone deacetylase inhibitor suberoylanilide hydroxamic acid and TRAIL on human breast cancer cells
    Weiqiang Zhou
    Xiuyan Feng
    Shanchun Han Han
    Guangdi Guo
    Scientific Reports, 6
  • [42] The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) induces growth arrest and apoptosis in multiple myeloma (MM) and Waldenstrom's macroglobulinemia (WM) cell lines and patient tumor cells.
    Mitsiades, N
    Mitsiades, CS
    Poulaki, V
    Anderson, KC
    Treon, SP
    BLOOD, 2001, 98 (11) : 376A - 376A
  • [43] Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer
    Kelly, WK
    O'Connor, OA
    Krug, LM
    Chiao, JH
    Heaney, M
    Curley, T
    MacGregore-Cortelli, B
    Tong, W
    Secrist, JP
    Schwartz, L
    Richardson, S
    Chu, E
    Olgac, S
    Marks, PA
    Scher, H
    Richon, VM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (17) : 3923 - 3931
  • [44] Cancer biology: mechanism of antitumour action of vorinostat (suberoylanilide hydroxamic acid), a novel histone deacetylase inhibitor
    Richon, V. M.
    BRITISH JOURNAL OF CANCER, 2006, 95 (Suppl 1) : S2 - S6
  • [45] Clinical experience with the novel histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid) in patients with relapsed lymphoma
    O A O'Connor
    British Journal of Cancer, 2006, 95 : S7 - S12
  • [46] The histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates human astrocyte neurotoxicity induced by interferon-γ
    Hashioka, Sadayuki
    Klegeris, Andis
    McGeer, Patrick L.
    JOURNAL OF NEUROINFLAMMATION, 2012, 9
  • [47] In silico modification of suberoylanilide hydroxamic acid (SAHA) as potential inhibitor for class II histone deacetylase (HDAC)
    Usman SF Tambunan
    N Bramantya
    Arli A Parikesit
    BMC Bioinformatics, 12
  • [48] Cancer biology: mechanism of antitumour action of vorinostat (suberoylanilide hydroxamic acid), a novel histone deacetylase inhibitor
    V M Richon
    British Journal of Cancer, 2006, 95 : S2 - S6
  • [49] Therapy of spinal muscular atrophy using suberoylanilide hydroxamic acid, a second generation histone deacetylase inhibitor
    Hahnen, E
    Eyüpoglu, IY
    Brichta, L
    Haastert, K
    Tränkle, C
    Siebzehnrübl, FA
    Riessland, M
    Hölker, I
    Claus, P
    Romstöck, J
    Buslei, R
    Wirth, B
    Blüumcke, I
    ACTA NEUROPATHOLOGICA, 2005, 110 (03) : 326 - 326
  • [50] Clinical experience with the novel histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid) in patients with relapsed lymphoma
    O'Connor, O. A.
    BRITISH JOURNAL OF CANCER, 2006, 95 (Suppl 1) : S7 - S12
12345